MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

10 Hot Devices We Can't Get in the U.S.—Boston Scientific's Lotus TAVR

10 Hot Devices We Can't Get in the U.S.—Boston Scientific's Lotus TAVR
 

Boston Scientific's Lotus TAVR

Boston Scientific's Lotus Valve system is a transcatheter aortic valve that allows physicians to reposition and retrieve it before placement. Lotus earned CE Mark in October 2013 but is being studied in the REPRISE III pivotal trial in the United States.

Boston Scientific executives recently reported strong results in its Structural Heart division, naming Lotus as a significant contributor to that strength. At the company's recent investor day meeting, executives forecasted a U.S. launch of Lotus by the end of 2017.

             

[Image courtesy of BOSTON SCIENTIFIC CORP.]  

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish